With Kymriah nod in EU, Novartis is building a plant with up to 450 jobs
admin 27th August 2018 Uncategorised 0With the approval in Europe of its CAR-T cancer drug Kymriah, Novartis figures demand will call for more production. To crank that capacity up, the drugmaker will build a plant in Switzerland that eventually may employ 450 workers.
More: With Kymriah nod in EU, Novartis is building a plant with up to 450 jobs
Source: fierce